The REFER, ESCALATE and ACHIEVE in NI-IPP (REACH) Compendium was built on current scientific evidence and was developed for general ophthalmologists and specialists to help you achieve the best care for your patients who require treatment escalation beyond corticosteroids by explaining WHY, HOW, and WHEN to refer, treat, and collaboratively manage patients with NI-IPP.
Learning Objectives
The REACH compendium was developed as a learning resource to ensure:
- Accurate and timely referral of patients with suspected non-anterior NIU eligible for treatment escalation.
- Appropriate treatment escalation
- Ongoing collaboration between GO and specialists, post-non-corticosteroid systemic immunomodulatory therapy
Target Audience
This program is developed for general ophthalmologists and specialists who treat patients with non-infectious Intermediate, Posterior, and Panuveitis (NI-IPP).
CPD Credits
The REACH compendium is a non-accredited, continuing professional development program developed by an international scientific committee. It was also reviewed and adapted by a Canadian Scientific Committee to meet the needs of the Canadian ophthalmology audience:
Marie-Lyne Bélair, MD, FRCSC Université de Montréal Montréal, Québec | Larissa Derzko-Dzulynsky, MD, FRCSC University of Toronto Toronto, Ontario | Amin Kherani, MD, FRCSC University of Calgary Calgary, Alberta |
Access Details
Please visit the REACH microsite to access the REACH compendium and view other related-resources (i.e. Case studies, Patient Referral Tools, Clinical Perspective Videos.)